All In Biotech

Drug Trial Radar · NCT07104500

VK2735 for Weight Management Phase 3

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants Without Type 2 Diabetes Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition

Last checked: Nov 19, 2026Latest source record: Nov 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 4,500 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

4,500

Planned (sponsor's estimate)

Start

Jun 23, 2025

Primary completion

Jul 1, 2027

Study completion Aug 1, 2027

Sponsor

Lead sponsor
Viking Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Aug 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/m2) with one or more weight related comorbid condition without Type 2 Diabetes.

Conditions

  • Weight Loss

Interventions

  • VK2735Drug

    VK2735 is a peptide GLP-1 and GIP dual agonist administered Once Weekly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage change in body weight from baseline for participants receiving VK2735 after 78 weeks of treatmentTime frame: 78 Weeks

Locations

137 sites in 2 countries. Site status is shown where the registry gives one.

  • Viking Clinical Site #1037

    Birmingham, Alabama

  • Viking Clinical Site #1064

    Birmingham, Alabama

  • Viking Clinical Site #1128

    Huntsville, Alabama

  • Viking Clinical Site #1081

    Mobile, Alabama

  • Viking Clinical Site #1005

    Chandler, Arizona

  • Viking Clinical Site #1017

    Flagstaff, Arizona

  • Viking Clinical Site #1018

    Peoria, Arizona

  • Viking Clinical Site #1135

    Scottsdale, Arizona

  • Viking Clinical Site #1019

    Tucson, Arizona

  • Viking Clinical Site #1036

    Little Rock, Arkansas

  • Viking Clinical Site #1071

    Chula Vista, California

  • Viking Clinical Site #1070

    Escondido, California

  • Viking Clinical Site #1054

    Huntington Park, California

  • Viking Clinical Site #1014

    Lake Forest, California

  • Viking Clinical Site #1129

    Lemon Grove, California

  • Viking Clinical Site #1051

    Lincoln, California

  • Viking Clinical Site #1050

    Long Beach, California

  • Viking Clinical Site #1055

    Los Angeles, California

  • Viking Clinical Site #1078

    Manteca, California

  • Viking Clinical Site #1053

    Montclair, California

  • Viking Clinical Site #1068

    Panorama City, California

  • Viking Clinical Site #1132

    Rolling Hills Estates, California

  • Viking Clinical Site #1131

    San Diego, California

  • Viking Clinical Site #1104

    Santa Maria, California

  • Viking Clinical Site #1052

    Spring Valley, California

  • Viking Clinical Site #1109

    Tustin, California

  • Viking Clinical Site #1067

    Van Nuys, California

  • Viking Clinical Site #1079

    Walnut Creek, California

  • Viking Clinical Site #1119

    Denver, Colorado

  • Viking Clinical Site #1123

    Washington D.C., District of Columbia

  • Viking Clinical Site #1013

    Clearwater, Florida

  • Viking Clinical Site #1121

    Clearwater, Florida

  • Viking Clinical Site #1003

    Cooper City, Florida

  • Viking Clinical Site #1112

    DeLand, Florida

  • Viking Clinical Site #1107

    Delray Beach, Florida

  • Viking Clinical Site #1083

    Fort Myers, Florida

  • Viking Clinical Site #1058

    Jacksonville, Florida

  • Viking Clinical Site #1076

    Lakeland, Florida

  • Viking Clinical Site #1060

    Lakewood Rch, Florida

  • Viking Clinical Site #1117

    Miami, Florida

Showing 40 of 137 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.